Anti-tumor effects of Eribulin mesilate on clear cell sarcoma cell lines

被引：0
|
作者：
Nakai, Sho [1 ]
Nakai, Takaaki [1 ]
Yasuda, Naohiro [1 ]
Yamada, Shutaro [2 ]
Takenaka, Satoshi [1 ]
Imura, Yoshinori [3 ]
Tamiya, Hironari [3 ]
Tanaka, Takaaki [3 ]
Araki, Nobuhito [4 ]
Itoh, Kazuyuki [5 ]
Yoshikawa, Hideki [1 ]
Naka, Norifumi [3 ]
机构：
[1] Osaka Univ, Dept Orthop Surg, Osaka, Japan
[2] Yao Municipal Hosp, Dept Orthop Surg, Yao, Japan
[3] Osaka Int Canc Inst, Musculoskeletal Oncol Serv, Osaka, Japan
[4] Ashiya Municipal Hosp, Dept Orthop Surg, Ashiya, Japan
[5] Res Inst Nozaki Tokushukai, Osaka, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Sarcoma; differentiation; Eribulin mesilate;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1421
引用
收藏
页码：380 / 380
页数：1
相关论文
共 50 条
  • [1] Anti-tumor effects of Eribulin mesilate on clear cell sarcoma cell lines
    Nakai, Sho
    Nakai, Takaaki
    Yasuda, Naohiro
    Imura, Yoshinori
    Tamiya, Hironari
    Tanaka, Takaaki
    Otani, Hidetatsu
    Takenaka, Satoshi
    Hamada, Kenichiro
    Myoi, Akira
    Araki, Nobuhito
    Yoshikawa, Hideki
    Naka, Norifumi
    CANCER SCIENCE, 2018, 109 : 1415 - 1415
  • [2] Anti-tumor effects of a selective MET inhibitor on clear cell sarcoma cell lines
    Nakai, Takaaki
    Imura, Yoshinori
    Nakai, Sho
    Yasuda, Naohiro
    Yamada, Shutaro
    Takenaka, Satoshi
    Tamiya, Hironari
    Tanaka, Takaaki
    Araki, Nobuhito
    Itoh, Kazuyuki
    Yoshikawa, Hideki
    Naka, Norifumi
    CANCER SCIENCE, 2018, 109 : 569 - 569
  • [3] Anti-tumor effect and mechanisms of concurrent targeting EGFR and metabolism in sarcoma cell lines
    Wang, X.
    Yeo, R.
    Crowe, P.
    Goldstein, D.
    Hogg, R.
    Dilda, P.
    Yang, J. L.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S37 - S38
  • [4] Zebularine showed anti-tumor efficacy in clear cell renal cell carcinoma
    Xu, Haoyu
    Peng, Senlin
    Li, Junwu
    Bai, Yuanyuan
    Zhao, Guozhi
    Liang, Simin
    Tang, Wei
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [5] Eribulin has anti-tumor activity in a preclinical model of merkel cell carcinoma
    Miyamoto, K.
    Yanagi, T.
    Maeda, T.
    Kitamura, S.
    Ujiie, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S41 - S41
  • [6] ANTI-TUMOR AND SUPPRESSOR ACTIVITIES OF MACROPHAGE CELL LINES
    HOLDEN, HT
    TANIYAMA, T
    WHITE, SL
    VARESIO, L
    JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY, 1978, 24 (DEC): : A58 - A58
  • [7] Drug screening for anti-tumor effects on canine urothelial carcinoma cell lines
    Kodera, Yuka
    Soga, Kyoka
    Kato, Daiki
    Ikeda, Namiko
    Shinada, Masahiro
    Eto, Shotaro
    Yoshitake, Ryohei
    Li, Toshio
    Takahashi, Yosuke
    Hashimoto, Yuko
    Nishimura, Ryohei
    CANCER SCIENCE, 2022, 113 : 428 - 428
  • [8] Anti-tumor effect of taxol in oral cancer cell lines
    Myoung, H
    Kim, MJ
    JOURNAL OF DENTAL RESEARCH, 1999, 78 (05) : 1141 - 1141
  • [9] Anti-tumor effects of metformin on head and neck carcinoma cell lines: A systematic review
    Rego, Daniela Fortunato
    Elias, Silvia Taveira
    Amato, Angelica Amorim
    Canto, Graziela De Luca
    Silva Guerra, Eliete Neves
    ONCOLOGY LETTERS, 2017, 13 (02) : 554 - 566
  • [10] Mechanistic insight into anti-tumor effects of reversine in human myeloma and lymphoma cell lines
    McMillin, D. W.
    Negri, J.
    Hayden, P.
    Zurawska, J.
    Mitsiades, N.
    Richardson, P. G.
    Anderson, K. C.
    Mitsiades, C. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 143 - 144
12345